Hepatitis C Virus Infection, New England Journal of Medicine, vol.345, issue.1, pp.41-52, 2001. ,
DOI : 10.1056/NEJM200107053450107
Treatment failure in hepatitis C: Mechanisms of non-response, Journal of Hepatology, vol.50, issue.2, pp.412-432, 2009. ,
DOI : 10.1016/j.jhep.2008.11.010
Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection, New England Journal of Medicine, vol.360, issue.18, pp.1839-50, 2009. ,
DOI : 10.1056/NEJMoa0807650
URL : https://hal.archives-ouvertes.fr/inserm-00385235
Hepatitis C and liver transplantation, Nature, vol.77, issue.7053, pp.973-981, 2005. ,
DOI : 10.1053/jlts.2003.50268
New and experimental therapies for HCV, Nature Reviews Gastroenterology & Hepatology, vol.48, issue.7, pp.403-414, 2009. ,
DOI : 10.1038/nrgastro.2009.92
Hepatitis C virus entry: possible targets for therapy, Gut, vol.57, issue.12, pp.1728-1765, 2008. ,
DOI : 10.1136/gut.2007.141630
URL : http://gut.bmj.com/cgi/content/short/57/12/1728
Host neutralizing responses and pathogenesis of hepatitis C virus infection, Hepatology, vol.5, issue.1, pp.299-307, 2008. ,
DOI : 10.1002/hep.22307
URL : https://hal.archives-ouvertes.fr/inserm-00395783
Spontaneous Control of Primary Hepatitis C Virus Infection and Immunity Against Persistent Reinfection, Gastroenterology, vol.138, issue.1, pp.315-324, 2009. ,
DOI : 10.1053/j.gastro.2009.09.017
Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C, Proceedings of the National Academy of Sciences, vol.104, issue.14, pp.6025-6055, 2007. ,
DOI : 10.1073/pnas.0607026104
URL : https://hal.archives-ouvertes.fr/inserm-00395910
Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-Claudin-1 associations, Hepatology, vol.79, issue.4, pp.1144-57, 2010. ,
DOI : 10.1002/hep.23445
URL : https://hal.archives-ouvertes.fr/inserm-00705657
Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In Vitro, Journal of Virology, vol.76, issue.16, pp.8189-99, 2002. ,
DOI : 10.1128/JVI.76.16.8189-8199.2002
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC155162
Development of a TaqMan assay for the six major genotypes of hepatitis C virus: Comparison with commercial assays, Journal of Medical Virology, vol.102, issue.1, pp.72-81, 2008. ,
DOI : 10.1002/jmv.21043
Serum-Derived Hepatitis C Virus Infection of Primary Human Hepatocytes Is Tetraspanin CD81 Dependent, Journal of Virology, vol.82, issue.1, p.15 ,
DOI : 10.1128/JVI.01443-07
URL : https://hal.archives-ouvertes.fr/inserm-00374410
Claudin Association with CD81 Defines Hepatitis C Virus Entry, Journal of Biological Chemistry, vol.285, issue.27, 2010. ,
DOI : 10.1074/jbc.M110.104836
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898367